🦊/Investors

Connecticut Innovations

Government fund

New Haven · Pre-Seed–Growth · 10 people tracked

Find your way into Connecticut Innovations

1,726 people in our graph share verified history with the Connecticut Innovations team — schools, employers, funds. One of them is your warm intro.

Aydin Senkutunlockedknows Douglas Roth · together at Boston University (overlapped)
×2knows the team · via GE Capital
knows the team · via Boston College
×2knows the team · via The Wharton School
knows the team · via Yale University
knows the team · via Pequot Capital
Fox Verdict
Sign up to see your fit

Investment thesis

Connecticut Innovations invests capital and strategic support in early stage and growth companies based in Connecticut, aiming to strengthen the state as an innovation hub. It operates several dedicated funds: a $100M ClimateTech Fund for early stage and growth climate companies, a $50M AI/Q Fund targeting scalable commercial ventures at the intersection of artificial intelligence, quantum computing, and deep tech, a $50M Future Fund backing new and diverse ideas, people and industries, and a $200M evergreen Connecticut Bioscience Innovation Fund focused on bioscience. The organization emphasizes flexible financing across every stage of business development and hands-on operational support from experienced business partners.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Growth
Check
$500K – $2M
HQ
New Haven, Connecticut, US
Instruments
Equity
Founded
1989
Last 12 months
11 investments
AUM
$500M
Tracked investments
302
Unicorns
1
IPOs
6
Acquisitions
10

Team · 10 people

from the firm's website & curated & public directories

What they invest in

from 249 of 302 portfolio companies

Biotech ×71Healthtech ×71AI & Machine Learning ×63SaaS ×49Medical Devices ×33Enterprise Software ×31Digital Health ×29Deep Tech ×28

HQs:United States×165Israel×5Canada×3United Kingdom×3India×2Ireland×1

Who they back

founder profiles across 133 portfolio companies
44%
solo founders
59 of 133 mapped founding teams
38%
repeat founders
of 174 founders with career history
~3 yrs
old at investment
median across 36 dated deals

Founding team size:solo founder×592 founders×463 founders×184+ founders×10

Where their founders studiedfrom 163 founders with education data

Yale University ×11University of Connecticut ×7Massachusetts Institute of Technology ×6Princeton University ×6Columbia Business School ×5Columbia University ×5Cornell ×5Harvard University ×5

What their founders studiedfrom 156 founders with field-of-study data

Engineering ×36Business & Management ×28Computer Science ×28Life Sciences ×27Medicine ×14Mathematics & Statistics ×13Economics ×12Humanities ×11

Where their founders worked beforefrom 174 founders with career history

Yale University ×10Jpmorganchase ×4ATMI ×3Brigham and Women's Hospital ×3Crannog Software ×3HighCape Capital ×3UConn Health ×3Yale School of Medicine ×3

Accelerator rootsportfolio companies that came through a program

Techstars ×5Y Combinator ×2

51 founders hold a PhD · 26 hold an MBA (of 170 with degree data) · backed the same founder in 2+ companies: 2 founders

Investments · 302 tracked

founders shown can be your intro path

By year:2026 · 62025 · 72024 · 112023 · 72022 · 82021 · 52020 · 52019 · 22018 · 72017 · 52016 · 62015 · 487 dated

Arvinas Holding Co. LLCarvinas.comin𝕏NASDAQ: ARVN

Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.

BiotechHealthtechNew Haven, US

Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)inRandy Teel(President and Chief Executive Officer; Director)in

BoardStephen Squinto(Director)inLiam Ratcliffe(Director)inTim Shannon(Director)in

Co-investors5AM VenturesAccess BiotechnologyCanaan PartnersNextech InvestRA CapitalSolasta Ventures+1 more

Azitraazitrainc.comNYSE: AZTROct 2020 · $17M

Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.

AI & Machine LearningBiotechHealthtechFarmington, US

Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)

BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in

Co-investorsBios PartnersKdT VenturesLeaps by Bayer

Check Point Softwarecheckpoint.comin𝕏NASDAQ: CHKP

Check Point Software Technologies is a cybersecurity company providing security products and solutions.

AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareSaaSNew York, US

Gil ShwedMarius NachtinShlomo Kramerin

Co-investorsBlumberg CapitalBRM CapitalGlilot Capital PartnersInner Loop CapitalJAL Ventures Ltd.TLV Partners+2 more

Rallybio, LLCrallybio.comin𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5AM VenturesCanaan PartnersF-Prime CapitalMitsui Global InvestmentSolasta VenturesPivotal Life Sciences

Tantalus Systemstantalus.comin𝕏OTC: TGMPFDec 2016

Tantalus provides grid modernization technology for electric utilities, centered on a modular platform that delivers data interoperability across metering devices, substations, distribution circuits, and distributed energy resources from multiple vendors.

CleantechEnergyIoTBurnaby, US

Dermot O'Leary(Executive Officer)inPeter Londa(Executive Officer, Director)in

BoardAllen Beasley(Director)John McEwen(Director)Francis Harvey(Director)

Co-investorsPender Growth FundRedpoint Ventures

Veradermicsveradermics.cominNYSE: MANE

Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men.

BiotechHealthtechWest Hartford, US

Reid Waldman(Chief Executive Officer and Board Member)inTim Durso(Chief Technical Officer)inDominic Carrano(Chief Financial Officer and Treasurer)inMark Neumann(Chief Commercial and Strategy Officer)John W. Childs(Director)Jane Grant-Kels(Director)

Co-investorsLongitude CapitalOUP (Osage University Partners)SR One Capital Managementabrdn plcInvusLifeSci Venture Partners

Aeromics, LLCaeromics.comApr 2016✓ verified

Aeromics is a clinical-stage pharmaceutical company developing AER-271, an intravenous aquaporin-4 (AQP4) inhibitor designed to prevent cerebral edema (brain swelling) following severe, acute ischemic stroke.

BiotechHealthtechNew Haven, US

Dr. Pelletier(Co-founder)Dr. Boron(Founder)Marc Pelletier(Manager, Chief Executive Officer)William Boron(Co-founder)Paul McGuirk(Executive Officer)George Farr(Executive Officer)

Co-investorsBroadview Ventures

Cadenza Innovationcadenzainnovation.comin✓ verified

Cadenza Innovation develops a patented lithium-ion cell packaging architecture and battery energy storage systems focused on safety, energy density, and low cost.

CleantechEnergyHardwareBridgeport, US

Christina Lampe-Onnerud(CEO)inPer Onnerund(Executive Officer, Director)Christina Lampe-Onnerund(Executive Officer, Director)Per Onnerud(Chief Technology Officer)inDavid Feinberg(Executive Officer)Brian Chan(Executive Officer)in

Co-investorsGolden SeedsScale InvestorsScout Fund

Cloudsekcloudsek.comin𝕏Jan 2026 · $10M✓ verified

CloudSEK builds an AI-based external threat management platform that detects, analyzes, and reports cyber threats across the surface web, deep web, dark web, and internet-exposed infrastructure for organizations.

AI & Machine LearningCybersecuritySaaS

Rahul Sasi(Founder and CTO)inRahul Sasi (Shashi)(Founder)inSyed Shahrukh Ahmad(Founder)in

Co-investorsExfinity VenturesTenacity VenturesInflexor VenturesMassMutual VenturesCrane Venture PartnersPavestone

Encapsulateencapsulate.bioin✓ verified

Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days.

BiotechHealthtechMedical Devices

Armin Rad(Co-founder & CEO)inLeila Daneshmandi(Co-founder & COO)inArmin Rad, Ph.D.(Founder)inBret Schipper(CMO)inJohn Strahley(CFO)in

Co-investorsAmbit Health VenturesBlackwood Healthcare Breakthroughs

LambdaVision Incorporatedlambdavision.comin𝕏✓ verified

LambdaVision develops a protein-based artificial retina designed to restore vision for patients blinded by advanced retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration.

BiotechMedical DevicesSpace Tech

Robert R. Birge(Founder)Nicole L. Wagner(President and Chief Executive Officer)inJordan A. Greco(Chief Scientific Officer)in

Co-investorsAurelia FoundrySeraphim SpaceSeven Seven SixBand of AngelsE2MC Ventures

NourishedRxnourishedrx.comin✓ verified

NourishedRx operates a data-driven "Food is Health" platform that pairs clinically guided nutrition plans with support from Registered Dietitians, Health Coaches, and Wellness Associates to address chronic conditions, maternal health, surgical recovery, and nutrition insecurity.

Digital HealthFoodTechHealthtech

Lauren Driscoll(Founder & CEO)in

Co-investorsPrimetime PartnersS2G InvestmentsRoute 66 VenturesHDS CapitalPeakBridge VC

Omnicyteomnicyte.com✓ verified

OmniCyte is a biotechnology company developing vaccines and cancer immunotherapies, including a SARS-CoV-2 vaccine program and immune-response engineering work conducted in collaboration with academic medical centers.

BiotechHealthtechMedical DevicesNew York, US

Peter Leonardi(Founder and CEO)Angel Pellicer(Founder and Investigator)

Oxylus Energyoxylusenergy.comin✓ verified

Oxylus Energy develops electrolyzers that convert captured CO2 into low-carbon methanol using renewable power, which can be further upgraded into sustainable aviation fuels.

CleantechClimate TechEnergyNew Haven, US

Perry Bakas(Chief Executive Officer | Co-Founder)inHarrison Meyer(Cofounder)inConor Rooney(Chief Technology Officer | Co-Founder)in

Co-investorsAzolla VenturesEarth FoundryToyota VenturesEnergy Foundry

Perosphere Technologies Inc.perospheretech.comDec 2023✓ verified

Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status.

BiotechHealthtechMedical DevicesDanbury, US

Sasha Bakhru(Founder)inSolomon Steiner(Director)Michelle Brennan(Director)Daryl Mootoo(Executive Officer)Bakhru Sasha(Executive Officer, Director)Mark Pavao(Director)

Co-investorsAmbit Health Ventures

ProteoWise, Inc.proteowise.com✓ verified

ProteoWise develops the Hyperblot benchtop instrument for high-throughput multiplexed proteomics, letting researchers load samples and antibody panels to obtain quantified western-style protein data.

BiotechDeep TechHardwareNew Haven, US

Stephen M. Strittmatter(Co-founder & Chair, Scientific Advisory Board)Misha Kostylev(Founder)inErik Gunther(Chief Executive Officer & Co-founder)

BoardDaniel Wagner(Director)Benjamin D. Comb(Director)David Smoller(Director)

Co-investorsFoothill Ventures

Sustainable Real Estate Solutions, Inc.paceworx.comFeb 2010 · $1M✓ verified

SRS provides advisory, education, and technical support services for Commercial Property Assessed Clean Energy (C-PACE) financing, helping contractors, building owners, and mortgage holders reach consensus on energy-efficiency retrofit projects.

CleantechEnergyFintech

Brian McCarter(Founder & CEO)Peter Cashman(Founding Investor & Chief Operating Officer)inJim Bleecker(CFO)Gerry Tsui(Chief Technology Officer)

BoardAnthony Buonicore(Chairman)

Co-investorsLaunchCapital

Yuma Asset Managementyumaai.comOct 2025✓ verified

Yuma supports and accelerates projects building on Bittensor, a decentralized AI network, connecting entrepreneurs, developers, and businesses with resources to launch subnets.

AI & Machine LearningCrypto & Web3Deep Tech

Greg Schvey(Leader (appointed to lead growth))Jeff Schvey(Leader (appointed to lead growth))in

Co-investorsDigital Currency Group

1Touch1touch.ioin𝕏Acquired

1touch.io offers Kontxtual, a data security platform that continuously discovers sensitive data at rest and in motion, builds a contextual record per data element to track access, behavior, and exposure risk, and automates protection, compliance, and governance workflows.

AI & Machine LearningCybersecurityData & Infrastructure

Co-investorsMindset VentureNational Grid PartnersNeotribe VenturesOcean Azul PartnersJerusalem Venture Partners (JVP)SixThirty Ventures

3Gtms3gtms.comin𝕏Dec 2013

Shelton, US

Mitchell J Weseley(Executive Officer, Director)Mitch Weseley(Founder)inMark F Smith(Executive Officer)in

BoardScott McDonald(Director)Geoffrey Comrie(Director)Gene Tyndall(Director)

Co-investorsHercules Capital, Inc.

Abbratech Inc.abbratech.com

AbbraTech develops a platform technology for the discovery, engineering, and validation of antibodies, targeting disease-relevant proteins that are difficult to address with conventional approaches.

BiotechDeep TechBranford, US

Michael Weiner(Founder)in

Acadian Venturesacadianventures.comin

Acadian Ventures is an early-stage venture capital firm focused on the Future of Work, investing in companies such as Nomi Health, Oyster, SmartRecruiters, Degreed, and Utmost.

Enterprise SoftwareFuture of WorkSaaS

Jason Corsello(Founder & General Partner)inThomas Otter(General Partner)in

Co-investorsPeakEmblemFELIX CAPITALNotion CapitalUgly Duckling Ventures

Aceissaceiss.comAug 2022 · $3.3M

Aceiss detects unauthorized employee access to company systems and monitors user privileges across applications to prevent cyber attacks.

CybersecurityDeveloper ToolsEnterprise Software

Co-investorsCanaan PartnersInsight Partners

Achillion Pharmaceuticals, Inc.achillion.comin𝕏

Achillion conducts research and development focused on addressing rare disease challenges through investigation of new therapeutic targets, modalities, and technologies.

BiotechHealthtech

Co-investorsPappas CapitalSV Health InvestorsDomain Associates

ActiveCampaignactivehosted.comin𝕏

ActiveCampaign is a marketing automation platform that uses AI to manage email, SMS, and WhatsApp campaigns across integrated marketing channels.

AI & Machine LearningMarketing TechSaaS

Co-investorsAgilitas Private EquitySilversmith Capital PartnersSusquehanna Growth EquityTiger Global Management

Adaptiveadaptive.livein𝕏Jul 2026

Adaptive builds Exo, a runtime security layer for AI agents that authenticates each agent, isolates sessions in ephemeral sandboxed environments, enforces per-tool authorization guardrails, and logs all actions without exposing secrets.

AI & Machine LearningCybersecurityDeveloper ToolsEnterprise Software

Ronak Massand(Founder)in

Co-investorsAntlerAntler AustraliaBeresford VenturesHustle FundCongruent VenturesSeraphim Space+1 more

Adaptiveadaptiveinsurance.comin

Adaptive is a specialty insurance and technology company that uses proprietary data models to offer parametric coverage for emerging climate risks, such as power outages and wind/hail deductible buy-backs.

Climate TechFintechInsurTech

Michael Gulla(Founder)in

Co-investorsSeraphim SpaceSunna VenturesCongruent Ventures

Advanced Technology Materials, Inc.atmi.com

Gene Banucci(Founder)in

Advanced Telepsych, Inc.advancedtelepsych.orginJan 2021

Advanced TelePsych provides telepsychiatry services, including psychiatric evaluation and medication management, delivered by psychiatric professionals and mental health providers.

Digital HealthHealthtechMental HealthLongmeadow, US

Andrew Zaback(Executive Officer)

Alexion Pharmaceuticalsalexion.comin𝕏

Alexion is a biopharmaceutical company focused on research and development of treatments for rare diseases, serving rare disease patients and their families worldwide.

BiotechHealthtechBoston, US

Co-investorsAndera PartnersvenBio Partners

Allyx Therapeutics, Inc.allyxthera.comin𝕏

Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.

BiotechDigital HealthHealthtechNew Haven, US

Paul Fonteyne(Co-Founder)inStephen Strittmatter(Scientific Founder)inStephen Bloch(CEO & Co-Founder)inTimothy Siegert(COO, Co-Founder)inTim Siegert, PhD(COO & Co-Founder)Jennifer Gabler(Executive Officer)in

Co-investorsElm Street VenturesSpring Mountain CapitalWHIN

Alphina Therapeuticsalphinatx.comin

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)in

BoardColleen Cuffaro(Director)inMatthew Cohen(Director)in

Co-investorsCanaan PartnersHighCape CapitalOUP (Osage University Partners)

American Customer Care, Inc.americancustomercare.comin

American Customer Care provides customer support and engagement services for consumer product goods brands, including food and beverage, household products, personal care, and beauty companies.

AI & Machine LearningConsumerEnterprise SoftwareSaaS

AmpUpampup.ioin𝕏Sep 2024 · $15M

AmpUp develops electric vehicle charging infrastructure solutions for drivers, businesses, and communities.

Climate TechConsumerEnergyMobility & TransportationSaaSSan Francisco, US

Thomas Sun(Founder)in

Co-investors2.12 AngelsAutotech VenturesFoothill VenturesFrontier VenturesY CombinatorMuus Climate Partners+3 more

Anceraancera.comin

Ancera develops a software platform for food production that combines analytics, diagnostics, and automation to monitor, predict, and prevent risks such as pathogens and disease.

AgTechAI & Machine LearningFoodTechSaaSBranford, US

Arjun Ganesan(CEO)inHur Koser(Executive Officer, Director)in

BoardUgo DeBlasi(Director)McLeod Christopher(Director)Thomas Livingston(Director)

Co-investorsIAG Capital PartnersLaunchCapital

Anonybitanonybit.ioOct 2023 · $3M

Replacing passwords with biometric authentication

Frances Zelazny(Founder)in

Co-investorsAperture Venture CapitalFINTOP CapitalReflexive CapitalSwitch VenturesTarget GlobalTFX Capital+3 more

Apriligenapriligen.com

Apriligen develops autologous gene therapies for pediatric monogenic diseases, starting with Diamond Blackfan Anemia Syndrome.

BiotechHealthtechMedical Devices

Arccos Golf, LLCarccosgolf.com𝕏

Arccos is an AI-native golf performance platform trained on over 1.5 billion real golf shots that tracks a player's rounds and provides strokes-gained analytics, club recommendations, and on-course strategy.

AI & Machine LearningConsumerSports Tech

Sal Syed(Co-founder & CEO)inClinton Grusd(Co-founder)Ammad Faisal(Co-founder)

Co-investorsLaunchCapital

Asarasi, Inc.asarasi.comin𝕏Seed · Dec 2015 · $150K

Asarasi produces sparkling water made from maple tree sap, sourced sustainably from living trees as a renewable alternative to groundwater-based bottled water.

CleantechConsumerFoodTech

Adam Lazar(Founder)in

Athletic Brewing Holdings, LLCathleticbrewing.com𝕏

Athletic Brewing Company produces and sells non-alcoholic craft beer, including IPAs, lagers, sours, and radlers, through direct-to-consumer online sales.

ConsumerDirect to ConsumerFoodTechMilford, US

William Shufelt(Manager, Chief Executive Officer of the Issuer)John Walker(Director)in

BoardAlyssa Ferenz(Director)Harry Schwefel(Director)Timothy Barakett(Director)Harrison DiGia(Director)

Co-investorsGeneral Atlantic

AtlasXomicsatlasxomics.comin𝕏

AtlasXomics develops spatial epigenomics tools, spanning chip fabrication, hardware, and bioinformatics, for researchers studying areas such as cancer and systems biology.

BiotechDeep TechHealthtechNew Haven, US

Gregory Ho(Director)Richard Andersson(Director)

BoardKenneth Wang(Investor and entrepreneur (board member))

Avitus Orthopaedicsavitusortho.comin𝕏

Zimmer Biomet's Avitus Bone & Marrow Harvester is a minimally invasive suction curettage device designed for orthopedic surgeons to harvest cancellous bone and bone marrow, and to debride infected or diseased bone through small incisions at accessible sites like the tibia and calcaneus.

BiotechMedical DevicesFarmington, US

Maxim Budyansky(Executive Officer, Director)Neil Shah(Executive Officer, Director)

BoardPatrick O'Neill(Director)Paul Higham(Director)Terrence Coffey(Director)

Bagssecurebags.comin

Bags is a finance platform for small businesses that combines bookkeeping, accounting, and monthly CFO reporting with funding support, connecting clients to a network of 60+ lenders.

AI & Machine LearningFintechSaaS

Co-investorsLimited VenturesSlauson & Co.Zeal Capital Partners

Bekhealthbekhealth.comin

BEKhealth builds an AI-powered platform that reads structured and unstructured EHR data to support clinical trial feasibility, patient matching, and real-world data generation.

AI & Machine LearningDigital HealthHealthtechBranford, US

Joshua Ransom(Executive Officer)David Levin(Chief Executive Officer)inJosh Brown(Chief Technology Officer)inScott Caflisch(Chief Information Security Officer)inJeff Graham(Chief Data Officer)inJennifer Stacey(Chief Operating Officer)in

Co-investorsExcelerate Health VenturesHatteras Venture PartnersMartin Ventures

Better Rhodesbetterrhodes.comin𝕏Nov 2022

Better Rhodes is an online marketplace for non-alcoholic beverages, offering alcohol-free wines, craft NA beers, and monthly subscription clubs for people who want to drink mindfully.

ConsumerE-commerceMarketplacesMadison, US

Daniel Stiller(Executive Officer, Director)inChristopher Becker(Director)

Co-investorsWestchester AngelsClearco

Bexorgbexorg.cominOct 2025

Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains.

AI & Machine LearningBiotechDigital HealthMedical DevicesNew Haven, US

BoardZvonimir VrseljainNenad Sestan

Co-investorsAmplify PartnersThe Engine VenturesAmplify Partners CVE1 Ventures

Biohaven Pharmaceuticalsbiohavenpharma.comin𝕏

Biohaven is a biopharmaceutical company that discovers, develops, and commercializes treatments across immunology, obesity, neuroscience, and oncology, targeting rare and common diseases with limited treatment options.

BiotechHealthtech

Vlad Coric(Chairman & Chief Executive Officer)in

Co-investorsAisling CapitalAPERTURE Venture PartnersOUP (Osage University Partners)HBM Healthcare InvestmentsOrbiMed

Biologicsbiologicsmd.comFeb 2016

BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology.

BiotechHealthtechFayetteville, US

J. David Owens(Executive Officer, Director)Robyn Goforth(Executive Officer)Rob Gensure(Executive Officer)

BoardRamsay Ball(Director)Calvin Goforth(Director, Promoter)Lynn Kirkpatrick(Director)

Co-investorsHouston Angel NetworkRobin Hood Ventures

BioRez, Inc.biorez.com

BioBrace develops a reinforced bioinductive implant combining collagen scaffolds with PLLA microfilaments to support soft tissue repair, particularly for tendon healing procedures.

BiotechHealthtechMedical Devices

Co-investorsBantam GroupLaunchCapital

Biowave Corporationbiowave.comin𝕏Jan 2016

BioWave develops patented high-frequency neurostimulation devices that deliver therapeutic stimulation deep into the body to block pain signals at the nerve source, aimed at chronic pain patients and athletes.

HardwareHealthtechMedical DevicesNorwalk, US

Bradford Siff(CEO and Secretary)Brad Siff(Founder)inRobert Adler(President)inDavid Kratovil(Chief Operating Officer)in

BoardLance Lundberg(Director)L. Charles (Duke) Meythaler(Director)

Blitzblitznow.ininAug 2026 · $25M

Blitz provides fulfillment and delivery software that forecasts demand and optimizes inventory placement across locations, and offers pre-checkout delivery-timeline display and post-checkout order tracking for online retailers.

E-commerceLogistics & Supply ChainSaaS

Yash Sharma(Founder)in

Co-investorsBetter CapitalCapria VenturesFirst ChequeIndia QuotientAlteria CapitalInspired Capital+3 more

Bloom Creditbloomcredit.ioin𝕏

Bloom Credit provides credit data infrastructure and APIs that let banks, credit unions, and fintechs access validated tri-bureau consumer credit data, furnish Metro2-compliant reports, and build credit-building products.

Data & InfrastructureFintechSaaS

Corey KaplaninMatthew HarrisChristian Widhalm(CEO)inMike Esler(CTO)inMatt Keleshian(COO)inChrista Degnan(Chief Product Officer)in

Co-investors500 GlobalFlucas VenturesKindred Ventures

Bright Feedsbrightfeeds.comin𝕏

Bright Feeds converts unwanted or surplus food from companies into nutritious animal feed, aimed at reducing food waste and supporting sustainability goals.

Circular EconomyClimate TechFoodTech

Budderfly, Inc.budderfly.comin𝕏

Budderfly provides an Energy-as-a-Service model, installing and maintaining high-efficiency equipment at customer facilities at no upfront cost for qualifying sites and earning revenue from the resulting energy savings.

CleantechClimate TechEnergy

Al Subbloie(Founder and CEO)in

Bullishbullish.coin𝕏

Bullish is a creative agency and consulting firm that also provides capital, working with consumer brands.

ConsumerMarketing Tech

Brent Vartan(Founder)in

C2 Venturesc2ventures.coin𝕏

C2 Ventures is an early-stage venture capital firm that invests in enterprise AI-powered SaaS and robotics companies serving "Dirty, Dull, and Dangerous" legacy industries, as well as clean-tech and sustainability solutions.

AI & Machine LearningEnterprise SoftwareSaaS

Cadenzacadenza.vcin𝕏Oct 2024 · $2.8M

Cadenza is an investment platform that backs founders and management teams across technology, business services, and innovation-led industries, providing support in strategy, product, go-to-market, and hiring.

AI & Machine LearningCrypto & Web3FintechSector Agnostic

Kumar Dandapani(Managing Partner & Co-founder)inMax Shapiro(Managing Partner & Co-founder)in

Co-investorsMirana VenturesGolden SeedsScale InvestorsSocial Leverage

Cambiumcambium.comin

Cambium builds infrastructure and technology to connect buyers with sustainable wood materials and products.

B2B MarketplacesClimate TechLogistics & Supply ChainNew MaterialsCalifornia, US

Theo Hooker(Executive Officer, Director)inMarisa Repka(Executive Officer, Director)inBen Christensen(Founder & CEO)in

Co-investorsAvesta FundBlue Ivy VenturesCrosscut VenturesJuniperMaC Venture CapitalTunitas Ventures+3 more

Canaan Partnerscanaan.com

Eric Young(Founder)in

Co-investorsGrandBanks Capital

Canoteracanotera.comin

Canotera offers an AI and machine learning platform that forecasts the pathway, timing, costs, and outcomes of insurance claims, using documents, medical records, and expert assessments to produce calibrated settlement ranges anchored to comparable cases.

AI & Machine LearningInsurTechSaaS

Co-investorsRUNI Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Surface Travel Inc. d/b/a CuracityActualMedsAffomix CorporationAware Recovery CareAxioMx, Inc.Bactana Corp.Big WillowBIOPLEXUS, Inc.CGI Pharmaceuticals, Inc.ConduceConduce HealthConvexity ScientificCornovus PharmaceuticalsCypher AIFallCall SolutionsFitscriptFlyteHealth WebsiteGenaissance PharmaceuticalsGreenworks Lending Holdings, LLCHadapt, Inc.Innovatient SolutionsIpsogen, Inc.JodieKeisense, Inc.LifestyleCxLiveClipsLumedaM&M Media, Inc. a/k/a TrebelMeter HealthNetkey, Inc.New Haven PharmaceuticalsNovaTract Surgical

Browse all 302 investments with full details →

102 more tracked companies

Nuovo PastaOban BioPharmaOdinText Inc.OncoLuxOncoSynergyOneOovaOpen Solutions, Inc.OptifinoOutsiders FundOwl’s BrewP-TALP2 Science, IncPangolin TherapeuticsPanluminateParagon Networks InternationalPaygilantPCC Technology Group, LLCPeachPeer RoboticsPerospherePHȲNDPiroGonPopuli, Inc.Predictably Human, Inc.Premise CorporationPress Inc.PrevisicoProton OnSitePurpose BuiltPursueCareQ30 Sports ScienceQCDx LLCQuantum CircuitsQueen OneQuorusReekuReferWellRejuvenate BioRellevateReNetX BioreThoughtRevalia Bio, Inc.RevMedicaRho BioRNA ConnectRoundtrip EV Solutions Inc.Ruckus Media GroupSavant Systems, Inc.Scalable RoboticsSedentary Medical Solutions LLCSeeClickFixShelf Inc.SilverSkySimcha TherapeuticsSirona-Medical Technologies, Inc.Skyview VenturesSlideSloohSmartequipSmartPaySolais Lighting, Inc.Sonata ScientificSource DefenseSpiceSquare 9 SoftworksStanding Stone, Inc.StemifyStorry RoadStoryhubStovaSummerTalam BiotechTamarack GlobalTangen BiosciencesTastes NaturalThayerMahanThe Real FeelThetis Pharmaceuticals LLCTidal River FundTorigen PharmaceuticalsTrashieUmbie HealthUpSwing HealthValera HealthValisureVesey VenturesVistaraViziumvoiceittVortexWaldoWave Drowning Prevention SystemsWellinksWheelhouse GroupWRM SoftwareWymsicalXLerantZenapse, Inc. SaaS AIZetrOZZoneflow Reactor TechnologiesZorus

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 16

6 IPOs · 10 acquisitions · showing 10

Arvinas Holding Co. LLCNASDAQ: ARVNAzitraNYSE: AZTRCheck Point SoftwareNASDAQ: CHKPRallybio, LLCNASDAQ: RLYBTantalus SystemsOTC: TGMPFVeradermicsNYSE: MANEContinuity Control, Inc.acq. by MitratechDattoacq. by KaseyaMongooseacq. by IfByPhoneNufern, Inc.acq. by Coherent

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Azitra5.7%$5.00Jun 2023$3.4M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Connecticut Innovations made?
Connecticut Innovations has 302 tracked investments, 16 of which have exited, including 17 dated in the last 24 months.
What stage does Connecticut Innovations invest at?
Connecticut Innovations invests at the Pre-Seed, Seed, Series A, Series B, Growth stages.
What is Connecticut Innovations's typical check size?
Connecticut Innovations typically writes checks of $500K – $2M.
What sectors does Connecticut Innovations focus on?
Connecticut Innovations focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Consumer, Deep Tech, Enterprise Software, IoT, Quantum Computing, Sector Agnostic.
Where is Connecticut Innovations located?
Connecticut Innovations is headquartered in New Haven, US.
Who does Connecticut Innovations co-invest with?
Connecticut Innovations most often shares deals with Canaan Partners, LaunchCapital, Techstars, among 292 tracked co-investors.

Co-investors · 19

Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M
Ambit Health Ventures

Early-stage venture capital firm focused on digital health innovations including digital diagnostics, digital therapeutics, and tech-enabled services. Based in Boston and Philadelphia with deep clinical expertise and experience building and scaling healthcare ventures.

5AM Ventures

5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.

$100K – $4M
Jerusalem Venture Partners (JVP)

Jerusalem Venture Partners (JVP) is a venture capital firm investing across early and growth stages, building international category-leading technology companies out of Israel and New York.

Both backed · 2
$1.5M – $43M
Commerce Ventures

Commerce Ventures is a venture capital firm that partners with entrepreneurs building platforms for the future of retail and financial services.

Both backed · 1
$1M – $5M
Crosscut Ventures

Crosscut is an early-stage venture capital firm based in Los Angeles that backs founders building frontier technologies aimed at solving major societal challenges.

Both backed · 1
$250K – $750K
Primetime Partners

Primetime Partners is an early-stage venture capital fund that incubates and invests in companies transforming the quality of living for older adults, focused on the longevity economy.

Both backed · 1
$250K – $1M
National Grid Partners

National Grid Partners is the venture capital unit of National Grid plc, a major investor-owned energy utility company. The firm invests in innovative energy-related technologies and business models.

Both backed · 1
Digitalis Ventures

Digitalis Ventures invests in solutions to unmet needs in biomedicine and health, backing biotechnology and technology-enabled companies across human health and animal health.

Both backed · 1
$100K – $10M
Sony Ventures Corporation

Sony Innovation Fund is the corporate venture capital arm operated by Sony Ventures Corporation, investing in technology and entertainment startups worldwide.

Both backed · 1
Alpine Meridian

Alpine Meridian is an early-stage investment and advisory firm focused on the Internet, digital media, financial services, data, software, and e-commerce sectors, also providing advisory and financial structuring services to corporations and startups.

Both backed · 1
IA Capital Group

IA Capital Group is a venture capital firm founded in 2000 that invests in financial services and insurance technology companies, partnering with experienced management teams. It operates a strategic venture capital platform used by numerous insurers.

Both backed · 1
7 more co-investors

Flashpoint Venture CapitalHealthy VenturesLeta CapitalBlackwood Healthcare BreakthroughsConvective CapitalStarframeSway Ventures

Firms observed investing alongside Connecticut Innovations, from public investor directories. Shared companies are the overlap with Connecticut Innovations's recorded portfolio.

Similar investors

Featured in lists